Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 09, 2005	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001193125-05-023401.pdf 0001193125-05-023401.xls
Feb 09, 2005	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0000950123-05-001401.pdf 0000950123-05-001401.xls
Feb 04, 2005	8-K	Report of unscheduled material events or corporate event	View HTML 0000950172-05-000381.pdf 0000950172-05-000381.xls
Feb 01, 2005	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-05-000020.pdf 0001237899-05-000020.xls
Jan 25, 2005	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-05-000019.pdf 0001237899-05-000019.xls
Jan 20, 2005	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-05-000018.pdf 0001237899-05-000018.xls
Jan 14, 2005	5	Annual filing director officer or owner of more than ten percent.	View HTML 0001237899-05-000017.pdf 0001237899-05-000017.xls
Jan 11, 2005	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-05-000248.pdf 0000950123-05-000248.xls
Jan 07, 2005	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-05-000011.pdf 0001237899-05-000011.xls
Jan 07, 2005	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-05-000012.pdf 0001237899-05-000012.xls

Data provided by Kaleidoscope.

Investors & Media